Skeletal metastases from breast cancer: Imaging with nuclear medicine

Seminars in Nuclear Medicine

Volumn 29, Issue 1, 1999, Pages 69-79

  Cook, G J R ^a   Fogelman, I ^a  

^a GUY S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

BONE METASTASIS; BONE SCINTISCANNING; BREAST CANCER; CANCER STAGING; FOLLOW UP; HUMAN; ISOTOPE LABELING; POSITRON EMISSION TOMOGRAPHY; REVIEW; SCINTIMAMMOGRAPHY;

EID: 0032916328     PISSN: 00012998     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0001-2998(99)80031-2     Document Type: Article

References (61)

1. Coleman RE Rubens RD The clinical course of bone metastases from breast cancer Br J Cancer 55 1987 61 66
2. Richards MA Braysher S Gregory WM Advanced breast cancer: use of resources and cost implications Br J Cancer 67 1993 856 860
3. Mundy GR Metastatic bone disease Fogelman I Bone remodelling and its disorders 1995 Martin Dunitz London 104 122
4. Galasko CSB Tumours Galasko CSB Weber DA Radionuclide scintigraphy in orthopaedics 1984 Churchill Livingstone New York 65 110
5. Corcoran RJ Thrall JH Kyle RW Solitary abnormalities in bone scans of patients with extraosseous malignancies Radiology 121 1976 663 667
6. Rappaport AH Hoffer PB Genant HK Unifocal bone findings in scintigraphy. Clinical significance in patients with known primary cancer West J Med 129 1978 188 192
7. Perez DJ Powles TJ Milan J Detection of breast carcinoma metastases in bone: relative merits of X-rays and skeletal scintigraphy Lancet ii 1983 613 616
8. Kober B Hermann J Wetzel E Cold lesions in bone scintigraphy Fortschr Rontgenstr 131 1979 545 551
9. Fogelman I McKillop JH Greig WR Absent kidney sign associated with symmetrical and uniformly increased uptake of tracer by the skeleton Eur J Nucl Med 2 1977 257 260
10. Delpassand ES Garcia JR Bhadkamkar V Value of SPECT imaging of the thoracolumbar spine in cancer patients Clin Nucl Med 20 1995 1047 1051
11. Bushnell DL Kahn D Huston B Utility of SPECT imaging for determination of vertebral metastases in patients with known primary tumors Skeletal Radiol 24 1995 13 16
12. Han LJ Au-Young TK Tong WCM Comparison of bone SPET and planar imaging in the detection of vertebral metastases in patients with back pain Eur J Nucl Med 25 1998 635 638
13. Coleman RE Rubens RD Fogelman I Reappraisal of the baseline bone scan in breast cancer J Nucl Med 29 1988 1045 1049
14. Boxer DI Todd CE Coleman R Bone secondaries in breast cancer: the solitary metastasis J Nucl Med 30 1989 1318 1320
15. Jacobson AF Cronin EB Stomper EC Bone scans with one or two new abnormalities in cancer patients with no known metastases: frequency and serial scintigraphic behaviour of benign and malignant lesions Radiology 175 1990 229 232
16. Tumeh SS Beadle G Kaplan WD Clinical significance of solitary rib lesions in patients with extraskeletal malignancy J Nucl Med 26 1985 1140 1143
17. Jacobson AF Stomper PC Jochelson MS association between number and sites of new bone scan abnormalities and presence of skeletal metastases in patients with breast cancer J Nucl Med 31 1990 387 392
18. Baxter AD Coakley FV Finlay DB The aetiology of solitary hot spots in the ribs on planar bone scans Nucl Med Commun 16 1995 834 837
19. Kwai AH Stomper PC Kaplan WD Clinical significance of isolated scintigraphic sternal lesions in patients with breast cancer J Nucl Med 29 1988 324 328
20. Coakley FV Jones AR Finlay DB The aetiology and distinguishing features of solitary spinal hot spots on planar bone scans Clin Radiol 50 1995 327 330
21. Jacobson AF Stompe MD Cronin EB Bone scans with one or two new abnormalities in cancer patients with no known metastases: the reliability of interpretation of initial correlative radiographs Radiology 174 1990 503 507
22. Edelstyn GA Gillepsie PJ Grebell FS The radiological demonstration of osseous metastases: experimental observations Clin Radiol 18 1967 158 162
23. Galasko CSB The significance of occult skeletal metastases detected by scintigraphy in patients with otherwise early breast cancer Br J Surg 56 1975 757 764
24. Coleman RE Fogelman I Habibollahi F Selection of patients with breast cancer for routine follow up bone scans Clin Oncol 2 1990 328 332
25. Cook GJR Fogelman I Maisey MN Normal physiological and benign pathological variants of 18-fluoro-2-deoxyglucose positron emission tomography scanning: potential for error in interpretation Sem Nucl Med 24 1996 308 314
26. International union aginst cancer. Committee on clinical stage classification and applied statistics. The TNM system. General rules 1964
27. Nomura Y Kondo H Yamagata J Evaluation of liver and bone scanning in patients with early breast cancer based on results obtained from more advanced patients Eur J Cancer 14 1978 1129 1136
28. Davies CJ Griffiths PA Preston BJ Staging breast cancer. Role of scanning Br Med J 2 1977 603 605
29. Gerber FH Goodreau JJ Kirchner PT Efficacy or preoperative and postoperative bone scanning in the management of breast carcinoma N Engl J Med 297 1977 300 303
30. Citrin DL Furnival CM Bessent RG Radioactive technetium phosphate bone scanning in preoperative assessment and follow up study of patients with primary carcinoma of the breast Surg Gynecol Obstet 143 1976 360 364
31. Campbell DJ Banks AJ Davis GD The value of preliminary bone scanning in staging and assessing the prognosis of breast cancer Br J Surg 63 1976 811 816
32. Sklaroff RB Sklaroff DM Bone metastases from breast cancer at the time of radical mastectomy Cancer 38 1976 107 111
33. Ciatto S Pacini P Bravetti P Staging breast cancer—Screening for occult metastases Tumori 71 1985 339 344
34. Strender LE Lagergren C Wallgren A Role of bone scans in the initial assessment of operable patients with breast cancer Acta Radiol Oncol 20 1981 187 191
35. Kunkler IH Merrick MV Rodger A Bone scintigraphy in breast cancer: a nine year follow up Clin Radiol 36 1985 279 282
36. Furnival CM Blumgart LH Citrin DL Serial scintiscanning in breast cancer: indications and prognostic value Clin Oncol 6 1980 25 32
37. Ojeda MB Alonso MC Bastus R Follow up of breast cancer stages I and II. An analysis of some common methods Eur J Cancer 23 1987 419 423
38. Rosselli Del Turco M Palli D Cariddi A Intensive diagnostic follow up after treatment of primary breast cancer. A randomised trial (National Research Council Project on Breast Cancer Follow UP) JAMA 271 1994 1593 1597
39. Haywood JL Carbone PP Heuson JC Assessment of response to therapy in advanced breast cancer Eur J Cancer 13 1977 89 94
40. Coombes RC Dady P Parsons C Assessment of response of bone metastases to systemic treatment in patients with breast cancer Cancer 52 1983 610 614
41. Hortabagyi GN Libshitz HI Seabold JE Osseous metastases of breast cancer. Clinical, biochemical radiographic and scintigraphic evaluation of response to therapy Cancer 55 1984 577 582
42. Palazzo S Liguori V Molinari B Is the carcinoembryonic antigen test a valid predictor of response to medical therapy in disseminated breast cancer Tumori 72 1986 515 518
43. Coleman RE Mashiter G Whitaker KB Bone scan flare predicts successful systemic therapy for bone metastases J Nucl Med 29 1988 1354 1359
44. Schneider JA Divgi CR Scott AM Flare on bone scintigraphy following Taxol chemotherapy for metastatic breast cancer J Nucl Med 35 1994 1748 1752
45. Coleman RE Rubens RD Bone metastases and breast cancer Cancer Treat Rev 12 1985 251 270
46. Bitran JD Beckerman C Desser RK The predictive value of serial bone scans in assessing response to chemotherapy in advanced breast cancer Cancer 45 1980 1562 1568
47. Erdi YE Humm JL Imbriaco M Quantitative bone metastases analysis based on image segmentation J Nucl Med 38 1997 1401 1406
48. Pitt WR Sharp PF Comparison of quantitative and visual detection of new focal bone lesions J Nucl Med 26 1985 230 236
49. Condon BR Buchanan R Garvie N Assessment of progression of secondary bone lesions following cancer of the breast or prostate using serial radionuclide imaging Br J Radiol 54 1981 18 23
50. Dunker CM Carrio I Berna L Radioimmune imaging of bone marrow in patients with suspected bone metastases from primary breast cancer J Nucl Med 31 1990 1450 1455
51. Reske SN Karstens JH Gloekner W Radioimmunoimaging for diagnosis of bone marrow involvement in breast cancer and malignant lymphoma Lancet 1 1989 299 301
52. Bourgeois P Gassavelis C Malarme M Bone marrow scintigraphy in breast cancer Nucl Med Commun 10 1989 389 400
53. Kashyap R Babbar A Sahai I Tc-99m (V) DMSA imaging. A new approach to studying metastases from breast carcinoma Clin Nucl Med 17 1992 119 122
54. Lam AS Kettle AG O'Doherty MJ Pentavelent 99mTc-DMSA imaging in patients with bone metastases Nucl Med Commun 18 1997 907 914
55. Petren-Mallmin M Andreasson I Ljunggren O Skeletal metastases from breast cancer: uptake of 18-F fluoride measured with positron emission tomography in correlation with CT Skeletal Radiol 27 1998 72 76
56. Hawkins RA Choi Y Huang SC Evaluation of skeletal kinetics of fluorine-18-fluoride ion with PET J Nucl Med 33 1992 633 642
57. (abstract) Schirrmeister H Guhlmann CA Diederichs H Planar bone imaging Vs 18F-PET in patients with cancer of the prostate, thyroid and lung J Nucl Med 39 1998 113P 114P
58. Tse NY Hoh CK Hawkins RA The application of positron emission tomographic imaging with fluorodeoxyglucose to the evaluation of breast disease Ann Surg 216 1992 27 34
59. Wahl RL Cody RL Hutchins GD Primary and metastatic breast carcinoma: initial clinical evaluation with PET with the radiolabeled glucose analogue 2-[F-18]-fluoro-2-deoxy-D-glucose Radiology 179 1991 765 770
60. Moon DH Maddahi J Silverman DH Accuracy of whole body fluorine-18-FDG PET for the detection of recurrent or metastatic breast carcinoma J Nucl Med 39 1998 431 435
61. 18FDG PET: differing metabolic activity in osteoblastic and osteolytic lesions J Clin Oncol 16 1998 3375 3379